Drug Trial Radar · NCT01831765
Efficacy and Safety of FIAsp Compared to Insulin Aspart Both in Combination With Insulin Detemir in Adults With Type 1 Diabetes
Last checked: Nov 19, 2026Latest source record: Jun 12, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,290
Actual
Start
Aug 26, 2013
Primary completion
May 12, 2015
Study completion Jun 11, 2015
Sponsor
- Lead sponsor
- Novo Nordisk A/SNovo Nordisk (NVO)
- Sponsor type
- Industry
- First posted
- Apr 15, 2013
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This trial is conducted in Europe and the United States of America (USA). The aim of the trial is to investigate efficacy and safety of FIAsp (faster-acting insulin aspart) compared to insulin aspart, both in combination with insulin detemir in adults with type 1 diabetes. This trial consists of two periods: a 26 week treatment period followed by a 26 week additional treatment period.
Conditions
- Diabetes
- Diabetes Mellitus, Type 1
Interventions
Faster-acting insulin aspartDrug
Injected subcutaneously (s.c., under the skin), dose individually adjusted. Meal time dosing is defined as injecting 0-2 minutes before the meal.
insulin detemirDrug
Injected subcutaneously (s.c., under the skin), dose individually adjusted. Administrated once or twice daily.
insulin aspartDrug
Injected subcutaneously (s.c., under the skin), dose individually adjusted.
Faster-acting insulin aspartDrug
Injected subcutaneously (s.c., under the skin), dose individually adjusted. Post meal time dosing is defined as injecting 20 minutes after the start of the meal.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in HbA1c (Glycosylated Haemoglobin)Time frame: Week 0, week 26
Locations
191 sites in 9 countries. Site status is shown where the registry gives one.
Novo Nordisk Investigational Site
Mobile, Alabama
Novo Nordisk Investigational Site
Tucson, Arizona
Novo Nordisk Investigational Site
Tucson, Arizona
Novo Nordisk Investigational Site
Anaheim, California
Novo Nordisk Investigational Site
Concord, California
Novo Nordisk Investigational Site
Escondido, California
Novo Nordisk Investigational Site
Fresno, California
Novo Nordisk Investigational Site
Fullerton, California
Novo Nordisk Investigational Site
Inglewood, California
Novo Nordisk Investigational Site
La Jolla, California
Novo Nordisk Investigational Site
La Mesa, California
Novo Nordisk Investigational Site
Long Beach, California
Novo Nordisk Investigational Site
North Hollywood, California
Novo Nordisk Investigational Site
Northridge, California
Novo Nordisk Investigational Site
Poway, California
Novo Nordisk Investigational Site
San Diego, California
Novo Nordisk Investigational Site
Santa Barbara, California
Novo Nordisk Investigational Site
Santa Barbara, California
Novo Nordisk Investigational Site
Ventura, California
Novo Nordisk Investigational Site
Ventura, California
Novo Nordisk Investigational Site
Walnut Creek, California
Novo Nordisk Investigational Site
Denver, Colorado
Novo Nordisk Investigational Site
Newark, Delaware
Novo Nordisk Investigational Site
Boca Raton, Florida
Novo Nordisk Investigational Site
Coral Gables, Florida
Novo Nordisk Investigational Site
Fleming Island, Florida
Novo Nordisk Investigational Site
Fort Lauderdale, Florida
Novo Nordisk Investigational Site
Fort Lauderdale, Florida
Novo Nordisk Investigational Site
Jacksonville, Florida
Novo Nordisk Investigational Site
Miami, Florida
Novo Nordisk Investigational Site
Miami, Florida
Novo Nordisk Investigational Site
Miami, Florida
Novo Nordisk Investigational Site
Miami, Florida
Novo Nordisk Investigational Site
Miami, Florida
Novo Nordisk Investigational Site
Sanford, Florida
Novo Nordisk Investigational Site
Tampa, Florida
Novo Nordisk Investigational Site
Atlanta, Georgia
Novo Nordisk Investigational Site
Atlanta, Georgia
Novo Nordisk Investigational Site
Dunwoody, Georgia
Novo Nordisk Investigational Site
Lawrenceville, Georgia
Showing 40 of 191 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.